Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized, Double-Blind, Placebo-Controlled, Multinational Phase 3 Trial Of Iseganan In Prevention Of Ventilator-Associated Pneumonia

NCT00118781 is registered in ClinicalTrials.gov with IntraBiotics Pharmaceuticals as lead sponsor.

NCT NCT00118781
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00118781 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized, Double-Blind, Placebo-Controlled, Multinational Phase 3 Trial Of Iseganan In Prevention Of Ventilator-Associated Pneumonia
Lead sponsor
IntraBiotics Pharmaceuticals
Phase
Phase 2/3
Overall status
Terminated
Start date
September 30, 2003
Completion date
June 30, 2004
Enrollment
900
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pneumonia